Hydroxyurea-Induced Pneumopathy in a Patient With Myeloproliferative Syndrome

Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than 20 cases described, only 5 of which underwent an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Galván, Oriol Plans, Moltó, Hipólito Pérez, Fabià-Mayans, Ariadna, Xicoy, Blanca, Mate, José Luis, Martí, Pilar Ricart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993068/
https://www.ncbi.nlm.nih.gov/pubmed/29899671
http://dx.doi.org/10.1177/1179547618770688
Descripción
Sumario:Hydroxyurea (HU) is a drug frequently used in the treatment of chronic myeloproliferative neoplasms. The most common side effects of this drug are pancytopenia, digestive and skin disorders. Respiratory complications are rare and there are less than 20 cases described, only 5 of which underwent an anatomopathological study. We present the case of a patient with chronic myeloproliferative neoplasm who developed interstitial pneumonitis probably due to HU according to histological study.

Ejemplares similares